Form 4 for RMD ResMed|
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-08 · accession 0000943819-25-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-09 | 2025-09-08 | RMD | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 475.8K | +2% | +$814.0K |
| D | 2025-09-09 | 2025-09-08 | RMD | Farrell Michael J. | CEO | S - Sale+OE | $278.14 | -8,009 | 467.8K | -2% | -$2.23M |
| D | 2025-09-09 | 2025-09-08 | RMD | Farrell Michael J. | CEO | M - OptEx | $0.00 | -8,009 | 16.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-09-08 | M | A | 8,009 | $101.64 | 475,801 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-09-08 | S | D | 8,009 | $278.14 | 467,792 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $275.27 - $279.57. The price reported above reflects the weighted average sale price. |
| 3 | Derivative | ResMed Common Stock Options | 2025-09-08 | M | D | 8,009 | $0.00 | 16,020 | D | $101.64 · 2019-11-11 to 2025-11-14 | 8,009 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |